Table 1 Characteristics of women diagnosed with colorectal cancer across tumor stromal and epithelial eosinophil scoresa

From: Tumor eosinophil infiltration and improved survival of colorectal cancer patients: Iowa Women’s Health Study

Participant’s characteristics

Stromal eosinophil score

Epithelial eosinophil score

 

1

n=80

>1–2

n=164

>2–3

n=111

>3

n=86

P-valueb

1

n=250

>1–<2

n=114

≥2

n=77

P-valueb

Age at colorectal cancer diagnosis (years)

 ≤71

21.3

26.8

36.1

40.7

 

25.6

34.2

42.9

 

 72–77

37.5

45.7

35.1

37.3

 

42.4

40.4

31.2

 

 >77

41.3

27.4

28.8

22.1

0.02

32.0

25.4

26.0

0.05

BMI (kg/m2)c

 <25

27.5

37.2

36.0

46.5

 

36.8

35.1

40.3

 

 25–30

37.5

39.0

33.3

25.6

 

36.8

31.6

33.8

 

 >30

35.0

23.8

30.6

27.9

0.13

26.4

33.3

26.0

0.65

Smoking d

 Current

12.7

14.7

13.6

15.7

 

13.8

13.1

17.3

 

 Former

16.5

23.9

21.8

16.9

 

20.7

21.1

20.0

 

 Never

70.9

61.4

64.6

67.5

0.76

65.5

65.8

62.7

0.95

History of diabetes c

 Yes

13.8

12.8

17.1

17.4

0.68

21.6

15.8

16.9

0.36

History of hypertension c

 Yes

48.8

43.9

50.5

52.3

0.57

45.6

43.9

62.3

0.02

History of heart disease c

 Yes

25.0

15.9

24.3

14.0

0.10

21.6

15.8

16.9

0.36

Stage at diagnosis

In situ or local

20.0

30.5

33.3

45.4

 

28.6

41.2

32.4

 

 Regional

48.8

46.3

35.1

32.6

 

46.4

29.0

41.6

 

 Distant

20.0

12.2

13.5

8.1

 

13.5

12.3

13.0

 

 Unknown

11.3

11.0

18.0

14.0

0.03

11.5

17.5

13.0

0.12

Grade

 Well differentiated

3.8

4.9

6.3

7.0

 

5.2

6.1

5.2

 

 Moderately differentiated

50.0

61.6

66.7

62.8

 

58.4

64.9

63.6

 

 Poorly differentiated

41.3

29.3

23.4

24.4

 

31.2

24.6

28.6

 

 Lymphomas/not stated

5.0

4.3

3.6

5.8

0.37

5.2

4.4

2.6

0.84

Colorectal cancer site

 Colon proximal

63.8

60.4

52.3

43.0

 

56.0

53.5

58.4

 

 Colon distal/rectal

33.8

37.8

47.8

55.8

 

42.4

44.8

41.6

 

 Unspecified

2.5

1.8

0

1.2

0.04

1.6

1.7

0

0.80

Integrated pathway

 Traditional

33.9

33.8

37.1

50.8

 

35.0

44.4

39.7

 

 Alternate

6.8

13.2

7.9

15.9

 

9.4

14.8

12.7

 

 Serrated

32.2

25.7

28.1

17.5

 

26.1

22.2

30.2

 

 Unassigned

27.1

27.2

27.0

15.9

0.18

29.6

18.5

17.5

0.20

Surgery e

 No

43.8

32.9

39.6

29.1

 

36.8

36.8

31.2

 

 Yes

56.3

67.1

60.4

70.9

0.16

63.2

63.2

68.8

0.64

Chemotherapy e

 No

73.7

78.1

78.4

81.4

 

78.8

79.0

74.0

 

 Yes

26.3

21.9

21.6

18.6

0.70

21.2

21.1

26.0

0.65

Radiation e

 No

96.1

97.6

95.4

97.6

 

96.3

96.4

98.7

 

 Yes

3.9

2.4

4.6

2.4

0.25

3.7

3.6

1.3

0.59

Cytotoxic T-cell categories f

 1

     

24.9

10.5

10.4

 

 >1–2

37.9

27.7

13.8

14.0

 

42.9

38.6

29.9

 

 >2–3

38.0

41.4

34.0

29.1

 

14.7

29.8

24.7

 

 >3

24.1

30.9

52.3

57.0

0.0001

17.6

21.1

35.1

<0.0001

  1. aEpithelial and stromal eosinophil scores were assessed in epithelial and stromal areas of tumor, respectively.
  2. bThis is based on a chi-square test.
  3. cValue at the colorectal cancer diagnosis.
  4. dValue at baseline (in 1986).
  5. eInitial course of therapy.
  6. fCytotoxic T-cell (or CD8+ T cells) scores in epithelium and stroma were cross-tabulated with the corresponding eosinophil scores in epithelium and stroma. The categories in stromal cytotoxic T cells 1 and >1–2 were combined because of a very low frequency of stromal cytotoxic T cells in category=1.